blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0231622

EP0231622 - Inhibition of the 5-lipoxygenase pathway [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.06.1995
Database last updated on 15.06.2024
Most recent event   Tooltip07.03.1997Lapse of the patent in a contracting statepublished on 23.04.1997 [1997/17]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza P.O. Box 7929 Philadelphia
Pennsylvania 19103 / US
[N/P]
Former [1994/20]For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza P.O. Box 7929
Philadelphia Pennsylvania 19103 / US
Former [1987/33]For all designated states
SMITHKLINE BECKMAN CORPORATION
One Franklin Plaza P O Box 7929
Philadelphia Pennsylvania 19103 / US
Inventor(s)01 / Bender, Paul Elliot
504 Lilac Lane
Cherry Hill, NJ 08003 / US
02 / Hanna, Nabil
507 Kent Place
Berwyn, PA 19312 / US
03 / Sarau, Henry Martin
1880 Cindy Lane
Hatfield, PA 19440 / US
04 / Gleason, John Gerald
8 Heron Hill Drive
Downingtown, PA 19335 / US
05 / Lantos, Ivan
1447 Boxwood Drive
Blackwood, NJ 08012 / US
06 / Griswold, Don Edgar
205 Lower Valley Road
North Wales, PA 19454 / US
07 / Razgaitis, Kazys Arunas
7 Arthur road
Rosemont, PA 19010 / US
08 / Shilcrat, Susan Cathy
2 East Amherst Road
Bala Cynwyd, PA 19004 / US
[1987/33]
Representative(s)Waters, David Martin, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [1995/01]Waters, David Martin, Dr., et al
Smithkline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Former [1994/34]Waters, David Martin, Dr.
SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Former [1987/33]Waters, David Martin, Dr.
SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD / GB
Application number, filing date86309672.311.12.1986
[1987/33]
Priority number, dateUS1985080840712.12.1985         Original published format: US 808407
US1985080859512.12.1985         Original published format: US 808595
US1986085687528.04.1986         Original published format: US 856875
US1986085692828.04.1986         Original published format: US 856928
[1987/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0231622
Date:12.08.1987
Language:EN
[1987/33]
Type: A3 Search report 
No.:EP0231622
Date:24.05.1989
Language:EN
[1989/21]
Type: B1 Patent specification 
No.:EP0231622
Date:24.08.1994
Language:EN
[1994/34]
Search report(s)(Supplementary) European search report - dispatched on:EP05.04.1989
ClassificationIPC:C07D513/04, C07D471/04, C07D487/04, A61K31/425, A61K31/415, A61K31/435, A61K31/54, C07D207/22, C07D211/72, C07D277/18, C07D279/06
[1987/33]
CPC:
C07D471/04 (EP); C07D207/22 (EP); C07D211/72 (EP);
C07D277/18 (EP); C07D279/06 (EP); C07D487/04 (EP);
C07D513/04 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1987/33]
TitleGerman:Hemmung von Stoffwechselweg von 5-Lipoxygenasen[1987/33]
English:Inhibition of the 5-lipoxygenase pathway[1987/33]
French:Inhibition du métabolisme de la 5-lipoxygénase[1987/33]
Examination procedure24.12.1986Examination requested  [1987/33]
24.11.1989Despatch of a communication from the examining division (Time limit: M08)
01.08.1990Reply to a communication from the examining division
14.12.1990Despatch of a communication from the examining division (Time limit: M10)
25.11.1991Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
29.01.1992Reply to a communication from the examining division
20.02.1992Despatch of a communication from the examining division (Time limit: M04)
14.05.1992Reply to a communication from the examining division
10.07.1992Despatch of communication of intention to grant (Approval: No)
11.02.1993Despatch of a communication from the examining division (Time limit: M02)
07.04.1993Reply to a communication from the examining division
25.08.1993Despatch of a communication from the examining division (Time limit: M04)
03.12.1993Reply to a communication from the examining division
16.02.1994Despatch of communication of intention to grant (Approval: later approval)
23.02.1994Communication of intention to grant the patent
30.04.1994Fee for grant paid
30.04.1994Fee for publishing/printing paid
Opposition(s)25.05.1995No opposition filed within time limit [1995/33]
Request for further processing for:29.01.1992Request for further processing filed
30.01.1992Full payment received (date of receipt of payment)
Request granted
18.02.1992Decision despatched
Fees paidRenewal fee
22.11.1988Renewal fee patent year 03
25.11.1989Renewal fee patent year 04
29.11.1990Renewal fee patent year 05
25.11.1991Renewal fee patent year 06
13.11.1992Renewal fee patent year 07
02.11.1993Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [1995/30]deleted
Former [1995/15]DE25.11.1994
Documents cited:Search[Y]US3364112  (MARGARETHA RAEYMAKERS ALFONS H, et al);
 [X]DE2709639  (METABIO FA);
 [X]DE2742725  (SMITHKLINE CORP);
 [X]FR2365572  (SMITHKLINE CORP [US]);
 [Y]DE1900974  ;
 [X]EP0000353  (CIBA GEIGY AG [CH]);
 [YD]US4153706  (BENDER PAUL E, et al);
 [X]US4175127  (BENDER PAUL E [US], et al);
 [Y]US4186205  (BENDER PAUL E [US]);
 [Y]EP0011111  (SMITHKLINE CORP [US]);
 [X]EP0019668  (DIJKHUIS GEERT C [NL], et al);
 [A]EP0020858  (CIBA GEIGY AG [CH]);
 [XP]EP0203787  (SMITHKLINE BECKMAN CORP [US])
 [Y]  - CHEMICAL ABSTRACTS, vol. 100, no. 3, 16th January 1984, page 26, column 2, abstract no. 17343v, Columbus, Ohio, US; I. LANTOS et al.: "Antiinflammatory activity of 5,6-diaryl-2,3-dihydroimidazo(2,1-b)thiazoles. Isomeric 4-pyridyl and 4-substituted-phenyl derivatives"; & J. MED. CHEM. 1984, 27(1), 72-5
 [A]  - CHEMICAL ABSTRACTS, vol. 97, no. 19, 8th November 1982, page 708, abstract no. 162885x, Columbus, Ohio, US; A. ANDREANI et al.: "5,6-Disubstituted imidazo(2,1-b)thiazoles as potential antiinflammatory agents"; & EUR. J. MED. CHEM. - CHIM. THER. 1982, 17(3), 271-4
ExaminationEP0019688
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.